Core Viewpoint - Jiukang Bio has received a medical device registration certificate from the Beijing Drug Administration for products including the "Complement C1q Detection Kit" [2] Company Summary - Jiukang Bio (SZ 300406, closing price: 14.91 yuan) announced on August 14 that it has obtained a medical device registration certificate [2] - The company's revenue composition for the year 2024 is projected to be 100.0% from the healthcare sector [2]